While we're still getting used to amusing replies from SIRI on our iPhones, Sanofi has in-licensed a talking allergy therapy, Auvi-Q, which was approved by the U.S. Food and Drug Administration (FDA) only last week,...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)
+65 6592-6978